​

Zymeworks (ZYME) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ZYME Stock Forecast

Zymeworks (ZYME) stock forecast, based on 20 Wall Street analysts, predicts a 12-month average price target of $33.60, with a high of $40.00 and a low of $26.00. This represents a 34.78% increase from the last price of $24.93.

$5 $12 $19 $26 $33 $40 High: $40 Avg: $33.6 Low: $26 Last Closed Price: $24.93

ZYME Stock Rating

Zymeworks stock's rating consensus is Buy, based on 20 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 17 Buy (85.00%), 3 Hold (15.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 20 0 3 17 Strong Sell Sell Hold Buy Strong Buy

ZYME Price Target Upside V Benchmarks

TypeNameUpside
StockZymeworks34.78%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts566
Avg Price Target$33.40$32.17$32.17
Last Closing Price$24.93$24.93$24.93
Upside/Downside33.98%29.04%29.04%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 251101--12
Nov, 25291--12
Oct, 25172--10
Sep, 25172--10
Aug, 25172--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 12, 2025Wells Fargo$33.00$24.9332.37%32.37%
Dec 03, 2025JMP Securities$32.00$25.1027.49%28.36%
Nov 19, 2025Eva VerdejoWells Fargo$25.00$22.998.74%0.28%
Nov 19, 2025Stephen WilleyStifel Nicolaus$40.00$22.9973.99%60.45%
Nov 17, 2025Andrew BerensLeerink Partners$37.00$23.9054.81%48.42%
Oct 14, 2025Robert BurnsH.C. Wainwright$26.00$18.1143.57%4.29%
Nov 21, 2024Andrew BerensLeerink Partners$26.00$13.6890.06%4.29%
Nov 01, 2024Derek ArchilaWells Fargo$12.00$13.28-9.64%-51.87%
Oct 28, 2024Stephen WilleyStifel Nicolaus$28.00$13.11113.58%12.31%
Sep 25, 2024Robert BurnsH.C. Wainwright$12.00$12.50-4.00%-51.87%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 12, 2025Wells FargoCautiousOverweightupgrade
Dec 03, 2025CitigroupBuyOutperforminitialise
Nov 21, 2025B. RileyBuyBuyhold
Nov 19, 2025Wells FargoCautiousCautioushold
Oct 27, 2025H.C. WainwrightBuyBuyhold
Oct 14, 2025H.C. WainwrightBuyBuyupgrade
Oct 10, 2025B. RileyBuyinitialise
May 20, 2025Cowen & Co.Buyinitialise
Mar 07, 2025CitigroupBuyBuyhold
Nov 21, 2024Leerink PartnersOutperformOutperformhold

Financial Forecast

EPS Forecast

$-2K $-2K $-1K $-500 $0 $500 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.58$-4.06$1.91$-1.72$-1.62K----
Avg Forecast$-4.20$-4.55$-0.06$-1.96$-1.44$-1.75$-1.17$-1.91$-1.04
High Forecast$-1.37$-1.48$-0.03$-1.75$-1.30$-1.10$0.64$-0.98$-0.46
Low Forecast$-8.82$-9.56$-0.10$-2.29$-1.81$-2.20$-2.10$-3.06$-1.56
Surprise %-14.76%-10.77%-3283.33%-12.24%112238.19%----

Revenue Forecast

$0 $90M $180M $270M $360M $450M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$38.95M$26.68M$412.48M$76.01M-----
Avg Forecast$33.86M$15.63M$240.59M$74.79M$89.49M$84.38M$160.95M$156.89M$196.94M
High Forecast$62.49M$28.84M$370.44M$81.28M$114.37M$112.26M$160.98M$217.23M$272.69M
Low Forecast$16.31M$7.52M$143.38M$71.60M$72.84M$49.90M$160.92M$89.68M$112.57M
Surprise %15.03%70.74%71.44%1.64%-----

Net Income Forecast

$-150B $-110B $-70B $-30B $10B $50B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-180.55M$-211.84M$124.34M$-118.67M$-122.69B----
Avg Forecast$-114.30M$-254.98M$-280.48M$-118.67M$-113.67M$-116.02M$-69.54M$-166.65M$-71.62M
High Forecast$-91.44M$-203.99M$-224.39M$-94.94M$-89.37M$-75.99M$44.04M$-67.49M$-31.73M
Low Forecast$-137.16M$-305.98M$-336.58M$-142.41M$-124.36M$-151.24M$-144.71M$-210.72M$-107.42M
Surprise %57.97%-16.92%-144.33%-107838.70%----

ZYME Forecast FAQ

Is Zymeworks stock a buy?

Zymeworks stock has a consensus rating of Buy, based on 20 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 17 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Zymeworks is a favorable investment for most analysts.

What is Zymeworks's price target?

Zymeworks's price target, set by 20 Wall Street analysts, averages $33.6 over the next 12 months. The price target range spans from $26 at the low end to $40 at the high end, suggesting a potential 34.78% change from the previous closing price of $24.93.

How does Zymeworks stock forecast compare to its benchmarks?

Zymeworks's stock forecast shows a 34.78% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Zymeworks over the past three months?

  • December 2025: 8.33% Strong Buy, 83.33% Buy, 8.33% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 16.67% Strong Buy, 75.00% Buy, 8.33% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 10.00% Strong Buy, 70.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is Zymeworks’s EPS forecast?

Zymeworks's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.75, marking a -99.89% decrease from the reported $-1.618K in 2024. Estimates for the following years are $-1.17 in 2026, $-1.91 in 2027, and $-1.04 in 2028.

What is Zymeworks’s revenue forecast?

Zymeworks's average annual revenue forecast for its fiscal year ending in December 2025 is $84.38M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $160.95M, followed by $156.89M for 2027, and $196.94M for 2028.

What is Zymeworks’s net income forecast?

Zymeworks's net income forecast for the fiscal year ending in December 2025 stands at $-116M, representing a -99.91% decrease from the reported $-123B in 2024. Projections indicate $-69.542M in 2026, $-167M in 2027, and $-71.618M in 2028.